amsacrine has been researched along with Leukemia, Acute Monocytic in 5 studies
Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fouillard, L | 1 |
| Labopin, M | 1 |
| Meloni, G | 1 |
| Polge, E | 1 |
| Gorin, NC | 1 |
| Frassoni, F | 1 |
| Pérez, C | 1 |
| Campayo, L | 1 |
| Navarro, P | 1 |
| García-Bermejo, L | 1 |
| Aller, P | 2 |
| Wahlin, A | 1 |
| Brinch, L | 1 |
| Hörnsten, P | 1 |
| Evensen, SA | 1 |
| Oberg, G | 1 |
| Simonsson, B | 1 |
| Hedenus, M | 1 |
| Rius, C | 1 |
| Zorrilla, AR | 1 |
| Cabañas, C | 1 |
| Mata, F | 1 |
| Bernabeu, C | 1 |
| Bakic, M | 1 |
| Beran, M | 1 |
| Andersson, BS | 1 |
| Silberman, L | 1 |
| Estey, E | 1 |
| Zwelling, LA | 1 |
1 trial available for amsacrine and Leukemia, Acute Monocytic
| Article | Year |
|---|---|
Outcome of a multicenter treatment program including autologous or allogeneic bone marrow transplantation for de novo acute myeloid leukemia.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Amsacrine; Antineoplastic Combined Chemotherapy Proto | 1997 |
4 other studies available for amsacrine and Leukemia, Acute Monocytic
| Article | Year |
|---|---|
Comparison of BAVC to BuCy regimens in autologous stem cell transplantation for adult patients with acute myeloid leukemia.
Topics: Adolescent; Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carmus | 2004 |
The action of the DNA intercalating agents 4'-(9-acridinylamino) methanesulphon-m-anisidide and 1,4-bis(butylamino) benzo[g]phthalazine in U-937 human promonocytic cells: relationship between cell cycle and differentiation.
Topics: Amsacrine; Cell Cycle; Cell Differentiation; DNA-Binding Proteins; G2 Phase; Humans; Intercalating A | 1994 |
Differentiation of human promonocytic leukemia U-937 cells with DNA topoisomerase II inhibitors: induction of vimentin gene expression.
Topics: Amsacrine; Antigens, Differentiation; Cell Differentiation; Cell Division; Etoposide; Gene Expressio | 1991 |
The production of topoisomerase II-mediated DNA cleavage in human leukemia cells predicts their susceptibility to 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA).
Topics: Aminoacridines; Amsacrine; Cell Line; DNA Topoisomerases, Type II; DNA, Neoplasm; Drug Resistance; H | 1986 |